Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Spiral Therapeutics is a clinical-stage pharmaceutical company delivering therapies for inner ear disorders.
Beacon Biosignals is a neurotechnology company that brings precision neuroscience into clinical trials and treatments.
Hyperfine makes MRI accessible to every patient regardless of income or resources.
Imperative Care is singularly dedicated to finding meaningful answers to unsolved problems in stroke.
Dianthus Therapeutics is a biotech company developing new treatments for serious autoimmune diseases using a more targeted approach.
Compass Pathways is a mental health care company that focuses on developing therapies for treatment-resistant depression.
ProSomnus designs and manufactures intraoral devices designed to help dentists get patients into therapy with comfort.
PrognomiQ is a biotechnology firm that develops test products to detect early disease detection through the power of multi-omics data.
Medra AI develops an autonomous scientific experimentation platform that combines robotics with artificial intelligence.
Sidera Bio harness human genetics, that helps in transformative medicines for patients.
Protara Therapeutics develops transformative therapies for people with cancer and rare diseases with limited treatment options.
AtaiBeckley develops innovative mental health treatments that address significant unmet medical needs.
Fractyl Health is a biotechnology company that provides curative therapies for metabolic diseases.
Volastra Therapeutics is a biotechnology company developing novel therapies for the treatment of metastatic cancers.
Ensomaa is a genomic medicine company that develops on one-time in vivo treatments for immuno-oncology and other therapeutic applications.
Character Bio is a platform that merges genomics with clinical data and AI technology, focusing on patients affected by AMD.
OSPRI is updating the infectious illness testing plan.
Amalgam Rx develops and distributes digital health products that support patients and healthcare providers in decision-making.
SetPoint Medical provides a device-based therapy for rheumatoid arthritis.
Avalyn Pharma is a biopharma company developing therapies for the treatment of idiopathic pulmonary fibrosis and other respiratory diseases.
Visby Medical is a diagnostics company that develops polymerase chain reaction diagnostic tests for the detection of infectious diseases.
Syndeio Biosciences is a newly launched biotech company pioneering precision neurotherapeutics.
GlycoEra is a biotechnology research company that produces extracellular protein degraders for the treatment of autoimmune diseases.
Imbria Pharmaceuticals is a clinical stage biotechnology company developing novel therapies for cardiometabolic diseases.
Catalio Capital Management has invested in 139 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Catalio Capital Management's top investment sectors include Biotechnology, Health Care, Medical, Medical Device, Therapeutics. The firm invests across 25 different industry categories.
Among tracked funding rounds, Dianthus Therapeutics received $719.0M in a Post-IPO Equity round. Catalio Capital Management's total known invested capital is $11.4B.
Catalio Capital Management's average investment size is $82.0M across its portfolio of 139 companies.
Recent Catalio Capital Management portfolio additions include Spiral Therapeutics, Beacon Biosignals, Hyperfine, Imperative Care, Dianthus Therapeutics. These companies were founded in 2020 or later.